Cargando…
Quantitative Imaging and Radiomics in Multiple Myeloma: A Potential Opportunity?
Multiple Myeloma (MM) is the second most common type of hematological disease and, although it is rare among patients under 40 years of age, its incidence rises in elderly subjects. MM manifestations are usually identified through hyperCalcemia, Renal failure, Anaemia, and lytic Bone lesions (CRAB)....
Autores principales: | Tagliafico, Alberto Stefano, Dominietto, Alida, Belgioia, Liliana, Campi, Cristina, Schenone, Daniela, Piana, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912483/ https://www.ncbi.nlm.nih.gov/pubmed/33494449 http://dx.doi.org/10.3390/medicina57020094 |
Ejemplares similares
-
Development and definition of a simplified scoring system in patients with multiple myeloma undergoing stem cells transplantation on standard computed tomography: myeloma spine and bone damage score (MSBDS)
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2020) -
Radiomics and Artificial Intelligence for Outcome Prediction in Multiple Myeloma Patients Undergoing Autologous Transplantation: A Feasibility Study with CT Data
por: Schenone, Daniela, et al.
Publicado: (2021) -
Subspecialty Second-Opinion in Multiple Myeloma CT: Emphasis on Clinically Significant Lytic Lesions
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2020) -
How Can Imaging Help the Radiation Oncologist in Multiple Myeloma Treatment
por: Belgioia, Liliana, et al.
Publicado: (2020) -
Overview of radiomics in breast cancer diagnosis and prognostication
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2019)